# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-090849
Filing Date
2024-10-25
Accepted
2024-10-25 17:00:39
Documents
10
Period of Report
2024-12-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0217586-01.htm | DEF 14A | 1193335
2 | GRAPHIC | ttherapeuticsmd_logo.jpg | GRAPHIC | 38886
3 | GRAPHIC | tmarlan_sig.jpg | GRAPHIC | 14305
4 | GRAPHIC | timage_001.jpg | GRAPHIC | 21254
5 | GRAPHIC | timage_002.jpg | GRAPHIC | 12342
6 | GRAPHIC | timage_003.jpg | GRAPHIC | 21198
7 | GRAPHIC | tbarchart_001.jpg | GRAPHIC | 547781
8 | GRAPHIC | tbarchart_002.jpg | GRAPHIC | 555706
9 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1489260
10 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 885819
| Complete submission text file | 0001213900-24-090849.txt |  | 6135979

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 241397743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)